CPEX Completes Sale to FCB I Holdings

CPEX Pharmaceuticals, Inc. CPEX today announced that it has completed its previously announced sale to FCB I Holdings Inc. for $27.25 per share in cash. Stockholders approved the merger agreement between CPEX and FCB at a special meeting of stockholders held on March 24, 2011.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsAsset SalesHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!